FinancialBuzz.com News Commentary
The stock market rebounded as Wall Street tried to recover from the previous session; dubbed by some as the worst trading day since the Black Monday market crash of 1987. The Federal Reserve took measures to help the economy maintain its momentum in a face of system paralysis due to the recent coronavirus (COVID-19) outbreak. As markets reeled this week, the Federal Reserve announced a plan to pump USD 1.5 Trillion into short-term funding markets over the next two days to help stabilize the financial system, but that appeared to have little effect on Thursday. This was an addition to the Fed’s decision to cut interest rates by half a percentage point in an emergency move in the week prior and it was reported that analysts expect the central bank to cut rates again at its March 18th meeting. The rates affect the cost of borrowing on everything from credit cards to auto loans. “These changes are being made to address highly unusual disruptions in Treasury financing markets associated with the coronavirus outbreak. Reserve management purchases into the second quarter will continue to be conducted with this maturity allocation,” the Federal Reserve Bank of New York said in a statement on Thursday. U.S. Lithium Corp., iBio Inc, Alpha Pro Tech Ltd., Novavax, Inc., Aytu BioScience, Inc.
In response to the outbreak, governments around the world have focused their resources on curing COVID-19. Besides the research necessary to develop a vaccine, accelerated R&D also focuses on diagnostic techniques, specifically on the scope of blood testing services throughout the industry. For example, researchers around the world are racing to develop antibody tests, also called serological tests, that can confirm whether someone was infected even after their immune system has cleared the virus. According to a report published by American Association for the Advancement of Science (AAAS), disease trackers in Singapore have used an experimental antibody test for COVID-19 to confirm that a suspected patient was infected with the coronavirus. The patient was one of two people who, together, formed a missing link between two clusters of cases that each occurred in a Singaporean church. “The group that developed the test, at Duke-NUS Medical School in Singapore, is among the front-runners, although its assay has to be validated before it is taken into production and deployed widely. In blood samples from recovered patients, the team identified antibodies targeting the spike protein that proved able to block the virus from killing cells in laboratory tests. In parallel, they created synthetic viral proteins that can detect those antibodies in a blood sample without having to use the live virus,” AAAS explains.
Marketing Technology News: DisruptOps Raises $9 Million Series A to Scale Cloud Security Operations
U.S. Lithium Corp., soon to be renamed BioELife Corp., announced earlier last week breaking news that “the Company’s chemists and medical advisors have completed their specifications for, and selection of, virus and bacteria protection products including a powerful hand sanitizer fortified with CBD and ultra-protective Nano-Fiber Face Masks. The masks will be manufactured by Respilon, a leading producer of nanofiber products. These products will be part of the Company’s BioEDefender product line and are now available for pre-order on the Company’s ecommerce site, with expected fulfillment the first week of April.
The core of the masks consists of the latest technology using four layers of protection including a nanofiber membrane, RespiPro, with a 60 nano-meter opening that mechanically captures 99.9% of viruses and bacteria. These masks also contain a revolutionary layer of fabric with accelerated copper dioxide (ACuO) which deactivates viruses and bacteria with a 99.9% efficiency. This new pathogen-deactivating feature helps reduce the spread of viruses. The masks can be reused for several days and are not considered biohazardous material after use. A second version, the Respiratory Shield, also has a Bacterial and Virus Filtration Efficiency of 99.9% and with same benefits but was engineered for 50 washing cycles.
Marketing Technology News: EnergyBot Raises Series B Funding
The BioEDefense Hand Sanitizer is a proprietary formulation that combines Vitamin E, Aloe, and other nutrients fortified with pure CBD in a blend with a 70% alcohol base. This exceeds the Center for Disease Control’s recommended alcohol potency for viral and bacterial defense and protection. While CBD is not a cure for the Coronavirus, its anti-bacteria, anti-anxiety, anti-inflammatory properties can assist and be very beneficial in the fight against this global pandemic.
Gregory Rotelli, Chairman of the Board and President of BioELife stated, ‘We are very proud of our emerging virus and bacteria protection product line which was specifically designed to aid this worldwide crisis. Our Respilon masks are by far the most effective available due to their revolutionary Nano-Fiber Technology and our BioEDefense Sanitizer exceeds The Center for Disease Control (CDC) Guidelines for viral and bacterial defense while being fortified with the beneficial proprieties of CBD. Most importantly, we are providing these critically important products on our ecommerce site, at an attractive value point compared to less effective options being sold by our competitors at much higher price points.’
Marketing Technology News: Ricoh Spins out Vecnos to Focus on Consumer 360-Degree Camera Segment
